# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001493152-24-048292
Filing Date
2024-12-02
Accepted
2024-12-02 16:05:26
Documents
20
Period of Report
2024-11-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form8-k.htm iXBRL | 8-K | 42772
2 |  | ex10-1.htm | EX-10.1 | 4284
3 |  | ex10-1_001.jpg | GRAPHIC | 447204
4 |  | ex10-1_002.jpg | GRAPHIC | 281755
5 |  | ex10-1_003.jpg | GRAPHIC | 134614
6 |  | ex10-1_004.jpg | GRAPHIC | 339453
7 |  | ex10-1_005.jpg | GRAPHIC | 28770
| Complete submission text file | 0001493152-24-048292.txt |  | 1964737

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL SCHEMA FILE | lixt-20241129.xsd | EX-101.SCH | 3519
9 | XBRL DEFINITION FILE | lixt-20241129_def.xml | EX-101.DEF | 29971
10 | XBRL LABEL FILE | lixt-20241129_lab.xml | EX-101.LAB | 36548
11 | XBRL PRESENTATION FILE | lixt-20241129_pre.xml | EX-101.PRE | 26994
23 | EXTRACTED XBRL INSTANCE DOCUMENT | form8-k_htm.xml | XML | 5391

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39717 | Film No.: 241519011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)